• Health & Medicine

Hormone therapy now available for newly diagnosed prostate cancer in Scotland 

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.   A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

20 January 2020

• Health & Medicine

New breed of targeted cancer drug gets initial ‘no’ for NHS in England  

A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change. A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change.

15 January 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019

• Health & Medicine

Bladder cancer treatment rejected for routine use on NHS in England


A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England. 
A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England.

26 November 2019

• Health & Medicine

Breast and kidney cancer drugs approved on NHS Scotland

Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney cancer. Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney cancer.

21 November 2019

• Health & Medicine
• Policy & Insight

NHS staff shortages: urgent action needed to safeguard cancer services and help more people survive

Progress in improving cancer survival is at risk of being limited by staff shortages, an inquiry into the future of cancer care in Scotland has concluded. Progress in improving cancer survival is at risk of being limited by staff shortages, an inquiry into the future of cancer care in Scotland has concluded.

18 November 2019

• Health & Medicine

Improving cancer screening: what does the latest review recommend?

What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look. What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look.

16 October 2019

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

Record numbers beating breast cancer in the UK

More than 130,000 UK breast cancer deaths have been avoided in the last 30 years, according to our new analysis published to mark breast cancer awareness month. More than 130,000 UK breast cancer deaths have been avoided in the last 30 years, according to our new analysis published to mark breast cancer awareness month.

4 October 2019

• Health & Medicine

Immunotherapy for triple negative breast cancer gets initial ‘no’ for NHS in England

An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England. An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.

3 October 2019